242 related articles for article (PubMed ID: 26635032)
21. Assessing the efficiency of free light chain assay in monitoring patients with multiple myeloma before and after autologous stem cell transplantation along with serum protein electrophoresis and serum protein immunofixation.
Dogaru M; Lazăr V; Coriu D
Roum Arch Microbiol Immunol; 2011; 70(1):15-22. PubMed ID: 21717807
[TBL] [Abstract][Full Text] [Related]
22. Best treatment strategies in high-risk multiple myeloma: navigating a gray area.
Bianchi G; Richardson PG; Anderson KC
J Clin Oncol; 2014 Jul; 32(20):2125-32. PubMed ID: 24888801
[TBL] [Abstract][Full Text] [Related]
23. Risk of antigen excess in serum free light chain measurements.
Daval S; Tridon A; Mazeron N; Ristori JM; Evrard B
Clin Chem; 2007 Nov; 53(11):1985-6. PubMed ID: 17954504
[No Abstract] [Full Text] [Related]
24. Biphenotypic plasma cell myeloma: two cases of plasma cell neoplasm with a coexpression of kappa and lambda light chains.
Jiwani S; Bornhost J; Alapat D
Int J Clin Exp Pathol; 2015; 8(7):8536-44. PubMed ID: 26339430
[TBL] [Abstract][Full Text] [Related]
25. Concentrations of Serum Free Light Chains in Kappa and Lambda Lesions in Light-Chain Myelomas.
Singh G
Lab Med; 2019 Apr; 50(2):189-193. PubMed ID: 30423164
[TBL] [Abstract][Full Text] [Related]
26. Serum-free light chain analysis: works in progress.
Merlini G
Clin Chem Lab Med; 2009; 47(9):1021-2. PubMed ID: 19728842
[No Abstract] [Full Text] [Related]
27. [Assessment of serum free light chain of patients with multiple myeloma and clinical significance thereof].
Sui WW; Yao HJ; Wang YF; Wang L; Zhang K; Xu Y; Qiu LG
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(44):3158-60. PubMed ID: 18269880
[TBL] [Abstract][Full Text] [Related]
28. Analytical performance and diagnostic potential of immunoassays determining intact immunoglobulin kappa/lambda ratios in monoclonal gammopathies.
Eckold J; Poenisch W; Drogies T; Kratzsch J; Teupser D; Thiery J; Bruegel M
Clin Lab; 2014; 60(9):1491-500. PubMed ID: 25291945
[TBL] [Abstract][Full Text] [Related]
29. Combined light chain immunofixation to detect monoclonal gammopathy: a comparison to standard electrophoresis in serum and urine.
Jenner W; Klingberg S; Tate JR; Wilgen U; Ungerer JP; Pretorius CJ
Clin Chem Lab Med; 2014 Jul; 52(7):981-7. PubMed ID: 24566368
[TBL] [Abstract][Full Text] [Related]
30. Application of Capillary Electrophoresis in Monoclonal Gammopathies and the Cutoff Value of Monoclonal Protein in Differential Diagnosis of Multiple Myeloma and Other Monoclonal Gammopathies.
Cao F; Zhang R; Xu L; Liu M; Yuan Y
Ann Clin Lab Sci; 2021 May; 51(3):400-407. PubMed ID: 34162571
[TBL] [Abstract][Full Text] [Related]
31. [A case of multiple myeloma showing marked differences in serum IgG levels between protein electrophoresis and turbidimetry].
Shin JW; Park R; Choi TY
Korean J Lab Med; 2008 Aug; 28(4):282-5. PubMed ID: 18728377
[TBL] [Abstract][Full Text] [Related]
32. Heavy/light chain specific immunoglobulin ratios provides no additional information than serum proteins electrophoresis and immunofixation for the diagnosis and the follow-up of intact immunoglobulin multiple myeloma patients.
Beaumont-Epinette MP; Moreau C; Besnard S; Latute F; Collet N; Sebillot M; Grosbois B; Bendavid C; Guenet L; Decaux O
Pathol Biol (Paris); 2015 Sep; 63(4-5):215-21. PubMed ID: 26319969
[TBL] [Abstract][Full Text] [Related]
33. Serum free light chains, not urine specimens, should be used to evaluate response in light-chain multiple myeloma.
Dejoie T; Corre J; Caillon H; Hulin C; Perrot A; Caillot D; Boyle E; Chretien ML; Fontan J; Belhadj K; Brechignac S; Decaux O; Voillat L; Rodon P; Fitoussi O; Araujo C; Benboubker L; Fontan C; Tiab M; Godmer P; Luycx O; Allangba O; Pignon JM; Fuzibet JG; Legros L; Stoppa AM; Dib M; Pegourie B; Orsini-Piocelle F; Karlin L; Arnulf B; Roussel M; Garderet L; Mohty M; Meuleman N; Doyen C; Lenain P; Macro M; Leleu X; Facon T; Moreau P; Attal M; Avet-Loiseau H
Blood; 2016 Dec; 128(25):2941-2948. PubMed ID: 27729323
[TBL] [Abstract][Full Text] [Related]
34. Serum free light chain ratio, total kappa/lambda ratio, and immunofixation results are not prognostic factors after stem cell transplantation for newly diagnosed multiple myeloma.
Giarin MM; Giaccone L; Sorasio R; Sfiligoi C; Amoroso B; Cavallo F; Cipriani A; Palumbo A; Boccadoro M
Clin Chem; 2009 Aug; 55(8):1510-6. PubMed ID: 19520760
[TBL] [Abstract][Full Text] [Related]
35. Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains.
Katzmann JA; Clark RJ; Abraham RS; Bryant S; Lymp JF; Bradwell AR; Kyle RA
Clin Chem; 2002 Sep; 48(9):1437-44. PubMed ID: 12194920
[TBL] [Abstract][Full Text] [Related]
36. The predictive power of serum kappa/lambda ratios for discrimination between monoclonal gammopathy of undetermined significance and multiple myeloma.
Bergón E; Miravalles E; Bergón E; Miranda I; Bergón M
Clin Chem Lab Med; 2005; 43(1):32-7. PubMed ID: 15653439
[TBL] [Abstract][Full Text] [Related]
37. Strengths and weaknesses of methods for identifying monoclonal free light chains of Ig: examples from two cases with renal disease.
Levinson SS
Clin Chem Lab Med; 2016 Jun; 54(6):1039-43. PubMed ID: 26368046
[TBL] [Abstract][Full Text] [Related]
38. Biochemical profile of Bence-Jones type multiple myeloma.
Lyubimova NV; Timofeev YS; Abaev VM; Votyakova OM; Osmanov EA; Kushlinskii NE
Klin Lab Diagn; 2022 Oct; 67(10):570-574. PubMed ID: 36315171
[TBL] [Abstract][Full Text] [Related]
39. Serum free light-chain measurements for identifying and monitoring patients with nonsecretory multiple myeloma.
Drayson M; Tang LX; Drew R; Mead GP; Carr-Smith H; Bradwell AR
Blood; 2001 May; 97(9):2900-2. PubMed ID: 11313287
[TBL] [Abstract][Full Text] [Related]
40. Serum and Urine Protein Electrophoresis and Serum-Free Light Chain Assays in the Diagnosis and Monitoring of Monoclonal Gammopathies.
Singh G
J Appl Lab Med; 2020 Nov; 5(6):1358-1371. PubMed ID: 33150391
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
